Catalyst Pharmaceuticals (NASDAQ:CPRX) departs Nasdaq as merger spread narrows to one cent
U.S. markets operated as usual on Tuesday, though Catalyst shares did not trade. Nasdaq halted trading activity after the company was acquired by Angelini Pharma.